The much-awaited Maruti Suzuki's electric SUV is all set to be launched in the Indian market on December 2, 2025 with ...

On 25 November 2025, Novartis Pharmaceuticals conducted a study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with ...

The Mahindra XEV 9S arrives as one of the most compelling family EVs in the market today. With prices starting at Rs 19.95 lakh, it undercuts expectat ...

Texas A&M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower ...

This approach has the potential to rejuvenate specific tissues affected by mitochondrial decline," author Gaharwar told ...

ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

Novartis is pricing Itvisma at a wholesale acquisition cost of $2.59 million, a company spokesperson told Fierce Pharma. At ...

Five years ago, I named Kia’s Telluride as my Zoomie Vehicle of the Year because it was near perfect. Not much has changed, ...

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...

For months, DOGE — with Elon Musk in charge — was trumpeted as a flagship reform engine of Donald Trump’s second term ...

How the film’s VFX maestros brought cinema’s deadliest planet to life, and gave the Predator emotional nuance for the first ...